Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Dendreon shares jump on news of prostate drug's European launch
Yahoo/Reuters
Mon, 03/3/14 - 10:03 am
Tags:
Dendreon, prostate cancer, Europe, Provenge
The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Mon, 02/24/14 - 11:15 am
Tags:
Spectrum Pharmaceuticals, Dendreon, Achillion, Ziopharm, Intrexon, Arena Pharmaceuticals, Idenix, Synta Pharmaceuticals, Sarepta Therapeutics, Myriad Genetics
Galena Biopharma: The Oncologist's Perspective On A Life Saving Therapy
Seeking Alpha
Thu, 02/20/14 - 08:12 am
Tags:
Galena Biopharma, NeuVax, Dendreon, Provenge, prostate cancer, vaccines, breast cancer
Dendreon: The Time Is Now
Seeking Alpha
Tue, 02/18/14 - 11:33 am
Tags:
Dendreon, JNJ, Provenge, Medivation
Contract Manufacturing: Often Ignored, But Potentially Profitable
Seeking Alpha
Mon, 02/3/14 - 04:02 pm
Tags:
contract drug manufacturing, ANI Pharmaceuticals, Dendreon, Teva Pharmaceuticals, NeoStem
What Does Dendreon Corporation's Fourth Quarter Mean For Investors?
Motley Fool
Mon, 02/3/14 - 09:38 am
Tags:
Dendreon, Provenge
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
Tags:
JPMHC 2014, GSK, Intercept Pharma, Acorda Therapeutics, Cell Therapeutics, Novartis, Sanofi, Alnylam, Idenix, Alexion, Galena Biopharma, Incyte, Clovis Oncology, Dendreon, Merck, Arena Pharmaceuticals
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
Tags:
JNJ, Medivation, prostatce cancer, Astellas, Dendreon, Sanofi, Zytiga, Xtandi, Provenge
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
Tags:
biotech, Vertex Pharmaceuticals, Orexigen, Retrophin, Valeant Pharmaceuticals, Questcor, Biomarin, Merck, NeoStem, Amgen, Gilead Sciences, Vanda, Keryx, Peregrine Pharmaceuticals, CelSci, Regeneron, Cempra, Dendreon, Clovis Oncology, Halozyme, NPS Pharmaceuticals
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Fierce Biotech
Tue, 12/31/13 - 11:42 am
Tags:
Argos, IPOs, Dendreon, AGS-003, personalized medicine, renal cell carcinoma
Dendreon: A Cautionary Tale For Biotech Investors
Wall St Cheat Sheet
Mon, 12/30/13 - 11:32 am
Tags:
Dendreon, Provenge
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Tags:
Inovio, Pharma CEOs, PDL-1, immunotherapy, Joseph Kim, Bristol-Myers Squibb, Roche, Dendreon, GSK, ImmunoCellular Therapeutics, Merck, Northwest Biotherapeutics
The Worst Biotech CEO of 2013 Is...
TheStreet.com
Tue, 12/17/13 - 08:48 am
Tags:
biotech, Vical, Ariad Pharma, Aveo Oncology, Dendreon, Amarin
Dendreon: Where Things Stand Now
Seeking Alpha
Mon, 12/9/13 - 08:42 am
Tags:
Dendreon
The Provenge Vaccine, A Hedge Fund Manager And The SEC
Pharmalot
Wed, 12/4/13 - 08:47 am
Tags:
SEC, prostate cancer, Provenge, Dendreon
5 FDA-Approved Drugs That Disappointed Investors in 2013
Motley Fool
Wed, 11/13/13 - 10:33 pm
Tags:
FDA, Amarin, Vivus, Dendreon, Arena Pharmaceuticals, Provenge, Vascepa, Iclusig, Ariad Pharmaceuticals, Belviq, Qsymia
Dendreon Has Another Disaster Quarter
Seeking Alpha
Wed, 11/13/13 - 10:59 am
Tags:
Dendreon, earnings
Dendreon to restructure after drop in cancer drug sales
Yahoo/Reuters
Tue, 11/12/13 - 09:17 am
Tags:
Dendreon, Provenge, restructuring
Will Dendreon Catch Johnson & Johnson or Fall Behind Celldex?
Motley Fool
Mon, 11/11/13 - 10:17 am
Tags:
Dendreon, JNJ, Celldex
Dendreon (DNDN) Expected to Report More Narrow Loss
Forbes
Fri, 11/8/13 - 10:29 am
Tags:
earnings, Dendreon

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.